Thus, whereas hPCL3S seemed to be somehow implicated in the regulation of IL6 expression, the mechanism is independent of the activation of the Wnt/β-catenin pathway in prostate cancer cells and might thus involve another cell-specific signaling pathway. Here, IL6 is linked to prostate carcinoma.